ICAM1 and cancer: ICAM‐1 causes tyrosine phosphorylation and Ca2+ flux in cytotoxic T cells in the presence of anti‐CD3, which stimulates T cell activity.[55] Several cytokines, including IL‐2 and IFN‐α, have been used as cancer therapies.